MOVE-FA is using the modified Friedreich Ataxia Rating Scale (mFARS) to gauge the impact of the drug on symptoms like upper and lower limb coordination, swallowing, speech, and upright stability.

In MOXIe, patients taking Skyclarys achieved a significant 2.4-point improvement in modified Friedreich’s Ataxia Rating Scale (mFARS) scores relative to the placebo group and also improved other ...

and at least a 1-point improvement in the modified Friedreich Ataxia Rating Scale (mFARS) as of their latest visit (2 participants at 12-months, and 1 participant at 6-months). LX2006 Continues to ...

The trial assessed treatment efficacy using the Scale for the Assessment and Rating of Ataxia (SARA), a standardized tool for evaluating ataxia severity, especially in cerebellar diseases.

PhD has given his Buy rating due to a combination of factors related to Larimar Therapeutics’ development of nomlabofusp for treating Friedreich’s ataxia. The anticipation surrounding the ...